Clin2
NCT07328373Possibly a fitRecruiting

Depression Relapse Predictors Study

HealthyMajor Depressive Disorder (MDD)

Part of Mental health clinical trials.

This trial looks at brain and genetic markers to understand why depression returns. It is for people with major depression who are not currently taking medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
204 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You must be an outpatient (not in the hospital).
  • You must have major depressive disorder according to standard criteria.
  • You must not be taking any psychiatric medication for at least 1 week.
  • You must not have other brain or mental health conditions.
  • You must not have hearing loss or other physical diseases.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06746155Recruiting
Predictors of relapse in major depression

This study looks at adults with major depressive disorder who have responded to treatment, to find out what might predict a relapse. You will wear a wrist activity monitor and complete questionnaires.

Calgary, Alberta
NCT07735143Not yet recruiting
Multi-omics study of major depressive disorder

This study collects health data and samples from people with major depression and healthy volunteers to learn more about the condition. It may help improve future treatments.

Shanghai
NCT07853365Not yet recruiting
Predicting depression treatment success

Researchers are studying what factors help predict how well people respond to depression treatment. By joining, you'll help them learn more about which treatments work best for different people, and you'll receive standard care with a one-month check-in.

NCT05630963Recruiting
Study sleep-like brain signaling in major depression

This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.

Belmont, Massachusetts
NCT07738497Not yet recruiting
Precision treatment for depression using biomarkers

This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.

NCT04581902Recruiting
Study blood and brain markers in moderate to severe depression

This study looks at changes in depression “markers” to understand what treatments help and why. You’ll have non-invasive brain stimulation and scans before and after treatment, over about 8 weeks.

San Francisco, California

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.